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doi:10.1016/j.ejvs.2010.08.017Abstract Objectives: Hybrid aortic arch repair procedure was introduced to reduce invasive-
ness in high-risk patients with aortic arch pathology. The good results are expanding its appli-
cation, but endoleak, particularly type I, remains its Achilles’ heel.
Design: We describe our experience with hybrid treatment of aortic arch diseases focussing on
techniques and results to avoid type I endoleak.
Materials and Methods: A total of 15 high-risk patients with zone 0e2 aortic arch pathology
underwent supra-aortic debranching on ascending aorta and proximal aortic arch reinforce-
ment with a Dacron prosthesis. Metachronously, the procedure was completed with endovas-
cular stent grafting (ESG).
Results: Median age was 70 years with a mean European System for Cardiac Operative Risk
Evaluation (EuroSCORE) of 12.7  6.8. One patient died between aortic debranching and
ESG. Mean time between surgical debranching and ESG was 32  27.7 days. No major neuro-
logical events occurred. Mean length of the landing zone for ESG was 3.8  0.8 cm. Computed
tomography (CT) angiography scan performed soon after operation, and at 3, 6, and 12 months
did not show any type I endoleak.
Conclusions: Supra-aortic debranching on ascending aorta with proximal aortic arch reinforce-
ment is a useful step to ensure a safe landing zone for ESG, reducing risk early to midterm of
endoleak. Longer term follow-up is required to confirm the viability of this technique.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.39 0239042333; fax: þ39
o.it (G. Gelpi).
ty for Vascular Surgery. PublisheAortic arch aneurysm surgery remains an invasive surgical
procedure that requires hypothermic circulatory arrest
with a mean reported mortality of 13% and a mean repor-
ted neurologic injury of 8%.1e3 Despite the introduction of
new surgical procedures4 that have improved outcomes,
surgery of the aortic arch remains a challenge. Followingd by Elsevier Ltd. All rights reserved.
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a combined vascular and endovascular approach has been
proposed for the treatment of aortic arch disease. This
‘hybrid’ technique consists of supra-aortic debranching
followed by ESG to exclude the aneurysm. This procedure
has reduced the incidence of neurologic events and
mortality, particularly in high-risk patients, but the repor-
ted incidence of endoleak, especially type I endoleak,
varies from 5% to 30%.5e7 In the current report, we describe
our experience with hybrid treatment of aortic arch
diseases focussing techniques and results to avoid type I
endoleak.
Materials and Methods
Between June 2004 and November 2009, 38 patients were
referred to our department for aortic arch pathology. As
many as 23 (60.5%) patients underwent conventional
surgery and 15 (39.4%) patients underwent supra-aortic
debranching, reinforcement of the aorta and ESG. These 15
patients were at high-risk for conventional aortic arch
surgery due to cardiovascular, neurologic or pulmonary co-
morbidities. Patient demographics and clinical risk factors
are shown in Table 1. Surgical indications were mainly
degenerative aortic arch aneurysms (80%), dilatation of
residual distal aortic arch/descending false lumen of
a previous treated type A dissection (13%) and penetrating
aortic ulcer (6%). In one patient, ascending aortic
replacement and aortic valve repair was performed at the
same time as supra-aortic debranching and, in another
patient, a double coronary artery bypass (with left internal
thoracic artery and saphenous vein graft) was done.
Preoperative evaluation was done by multislice computed
tomography (CT) scans to evaluate the extent of the
disease, predict the required length of the intended prox-
imal landing zone and to explore the anatomy of the supra-
aortic branches and the aortoeiliac axis for subsequent
endovascular access. All patients also underwent a coro-
nary angiography. The study was approved by the Ethics
committee.Table 1 Patients demographics and clinical risk factors (Polyvas
or >50% stenosis, previous or planned intervention on the abdomi
pulmonary disease).
Demographic
Age, median years
Male gender
Polyvascular disease
Chronic renal failure
COPD
Previous Myocardial Infarction
Previous cerebrovascular accident
Euroscore, mean  SD
Aortic Aneurysm Diameter, mean  SD
Aortic arch pathology Ishimaru zone 0
Aortic arch pathology Ishimaru zone 1
Aortic arch pathology Ishimaru zone 2Surgical technique
Under general anaesthesia, after median sternotomy, the
ascending aorta and the supra-aortic vessels are mobilised.
Systemic heparinisation is initiated. After reaching a mean
blood pressure of 80 mmHg, the ascending aorta is
tangentially clamped with a side-biting clamp and the
proximal part of a bi- or trifurcated Dacron vascular pros-
thesis (Uni-Graft K-DV; Aesculap, Tuttlingen, Germany) is
sutured end-to-side to the aorta (the third limb is handsewn
end-to-side to the bifurcated prosthesis). The position of
the proximal anastomosis on the ascending aorta is deter-
mined by the preoperative CT scan and by the trans-oeso-
phageal echocardiography aiming to obtain an adequate
landing zone for the ESG and to avoid atherosclerotic pla-
ques. The side-biting clamp is removed and, if possible, the
first limb is anastomosed directly end-to-end to the prox-
imal left subclavian artery (LSA). If this is not possible
secondary to aneurysmal involvement or displacement, the
first limb is tunnelled to the mid-portion of the subclavian
artery and an end-to-side anastomosis is performed through
a 4-cm subclavicle incision. The second limb is anastomosed
end-to-end to the left common carotid artery; then, the
third limb of the prosthesis is anastomosed to the innomi-
nate artery, in the same fashion. Non-invasive monitoring
of cerebral oxygen saturation by near-infrared spectros-
copy is used for cerebral monitoring during the debranch-
ing. We complete the procedure by reinforcing the proximal
aorta, immediately after the origin of the main trunk of the
new supra-aortic vessels, with a 4-cm-long Dacron tube
graft opened longitudinally and then wrapped around the
aorta. This location is chosen where the proximal part of
the future ESG is intended to be deployed. We generally use
the very proximal part of the bi-trifurcated graft that is not
used for the debranching, as a Dacron graft for the rein-
forcement. To better visualise the proximal and distal parts
of the reinforcement (the landing zone of the future ESG)
during the endovascular step, we mark each end of the
reinforcement with radio-opaque thread markers passed
around and fixed on to the reinforcement (Fig. 1).cular disease: One or more of claudication, carotid occlusion
nal aorta, limb arteries or carotids; COPD: chronic obstructive
N %
70 (56e78)
12 80
8 53.3
6 40
5 33.3
4 26.6
2 13.3
12.7  6.8
5.85  0.95 cm
3 20
7 46.6
5 33.3
Figure 1 Debranching of the supra-aortic vessels, with the
reinforcement of the aorta of the supposed landing zone and
radiopaque markers.
Figure 2 Endovascular Stent Graft: A and C radiopaque
makers of the landing zone, B reinforcement of the aorta.
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The ESG deployment is usually done as a second-stage
procedure after full recovery from the first surgical step.
Occasionally, if there is the need for a slave conduit via the
common iliac artery, the ESG is done a few days after the
first one. A new CT scan is always performed after the first
stage to estimate the diameter of the new landing zone of
the ESG; the diameter of the ESG is usually 10e20% over-
sized above the outer diameter of the reinforced proximal
neck. The ESG is deployed under general anaesthesia, in
the interventional cardiology suite, after surgical exposi-
tion of the femoral artery or of the slave conduit. Stent-
graft deployment is routinely performed under hypotensive
conditions (80 mmHg systolic pressure). The proximal
landing zone is easily localised by identifying the two radio-
opaque markers at either end of the reinforcement. The
main trunk of the newly created supra-aortic vessels is also
easily recognised by a circle radio-opaque marker posi-
tioned at its origin from the ascending aorta; this precau-
tionary measure avoids the possibility of covering the main
trunk of supra-aortic vessels with the ESG. The proximal
part of the implanted ESG is always expanded with an
occlusion balloon (Equalizer, Boston Scientific, USA), to
conform the ESG to the aorta; overinflation is routinely
performed and the aortic reinforcement protects against
aortic rupture or dissection. As a precautionary measure, in
cases of prior abdominal aortic aneurysm repair or non-
transposed LSA, cerebrospinal fluid (CSF) drainage catheter
is performed prior to ESG implantation.Three different commercially available stent-graft
systems, the Endofit stent graft, theGore TAG stent graft and
the Talent and the Valiant endovascular stent grafts, were
used. For the first three cases, the Endofit stent graft
(LeMaitre Vascular, Burlington, MA, USA) was used. The
remainderwere performedwith theGore TAG stent graft (W.
L. Gore & Assoc, Flagstaff, AZ, USA) (seven patients) and the
Talent and the Valiant endovascular stent graft (Medtronic
Inc., Santa Rosa, CA, USA) (four patients).
Follow-up surveillance was performed with serial
contrast spiral CT scan prior to patient discharge and then
at 3, 6 and 12 months, and annually thereafter. Magnetic
resonance angiography was used alternatively in cases of
chronic renal insufficiency or allergy to iodinated contrast
(Figs. 2 and 3).
Results
The diseases presented by of all the patients involved zones
0e2 according to the Ishimaru arch map.8 Four (26%)
patients were symptomatic (back pain or dysphonia) and
three (20%) were treated during the same hospital admis-
sion. None of the patients were emergent (no frank rupture
or haemodynamic instability). A total of 14 (93%) patients
underwent ‘off pump’ and only one patient with the
cardiopulmonary bypass due to the concomitant aortic
valve and ascending aorta surgery. Three patients (20%)
required a conduit on common iliac to allow safe intro-
duction of the ESG. There were no intra-operative or per-
ioperative deaths. One patient underwent re-exploration
for bleeding. One patient (6.6%) died suddenly at home in
the waiting period between the supra-aortic debranching
and the intended stent-graft placement; no autopsy was
done. Mean time between surgical debranching and ESG
repair was 32  27.7 days.
Mean intensive care unit (ICU) stay for the surgical
debranching step was 1.2  2.3 days. Overall mechanical
ventilation time per patient was 12  21.8 h; one patient
required re-intubation due to respiratory failure. Thirty-
Figure 3 Four years follow-up.
Figure 4 KaplaneMeier survival curve.
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both the surgical and endovascular procedures were 0% for
stroke or permanent paraplegia/paraparesis. One patient
developed axillary vein thrombosis. After 1 month of oral
anticoagulation, no signs of thrombosis were detected. A
left vocal cord palsy was noted in one case. One to four
ESGs were implanted and the mean number of ESGs per
case was 1.9  0.7. In the very first case, the LSA was not
debranched because of aneurysm involvement, and coil
embolisation was performed during EGS implantation to
avoid type II endoleak. Technically, in 100% of the cases,
the endovascular step succeeded. Follow-up is 100%
complete. After a mean follow-up time of 31.4  26.9
months, type Ia endoleak rate is 0%. No additional
secondary procedures were necessary in any patient to
treat endoleaks. In one patient, at a 5-year follow-up CT
scan, rupture of a flair of the ESG (Endofit) was noted with
a bulging of the ESG, but without any endoleak; in this
patient, a new ESG was implanted to cover the broken part,
preventing possible endoleak.
The mean length of the proximal landing zone was
3.8  0.8, and, in all cases, this length was easily identified
by the radio-opaque markers of the reinforcement.
Overall KaplaneMeier survival is 93.3% (Fig. 4).
Discussion
Surgery of aortic arch aneurysm is technically challenging,
requiring deep hypothermic circulatory arrest with selec-
tive cerebral perfusion. Despite recent improvements in
surgical outcomes, even in expert high-volume centres, it
carries a perioperative mortality ranging from 4% to 28%
and an adverse neurologic event rate ranging from 1% to
10%.1e3 The ‘hybrid’ technique of supra-aortic debranching
followed by ESG, initially developed to treat only high-risk
patients and patients not suitable for cardiopulmonary
bypass, has reported encouraging low incidence of
mortality and neurologic events, respectively, ranging from0% to 4% and 0%e3%.5,9,10 Our experience is in line with the
literature, reporting a perioperative mortality of 0%,
a midterm mortality of 6% (patient died awaiting the
endovascular step) and 0% incidence of neurologic events.
These results enhance the safety and the efficacy of the
hybrid technique for aortic arch disease. However, the
Achilles’ heel of the hybrid technique is the endoleak.
The reported incidence of endoleak ranges from 5% to 30%,
particularly for type I.5,6,9 We report a 0% endoleak rate.
We think that our good results are due to the following: (1)
In planning for the surgical step, we focus on creating a safe
long proximal landing zone for the ESG. Thus, to have
a longer landing zone, we prefer complete debranching,
positioning the main trunk of the new supra-aortic vessels
in the proximal part of the ascending aorta. This allows the
proximal landing zone to start from the mid-portion of the
ascending aorta, thereby allowing ESG deployment in
a straight vessel, achieving a better seal than in a curved
aortic arch. (2) We reinforce the aorta at the intended
landing zone for the ESG. This offers two advantages for
proximal ESG sealing. First, it creates a non-expandable
zone, providing a long (4e5 cm), linear, cylindrical neck
next to the aneurysm; second, the radio-opaque markers
easily point out the proximal landing zone for accurate
deployment of ESG. The reinforcement can also prevent
further dilatation of the aorta, particularly in this patient
population, which is prone to aneurysms, thus avoiding
future type I endoleaks as pointed out also by Piffaretti
et al.6 This non-expandable zone allows for safe oversize of
the ESG and protects against balloon over-dilatation of the
ESG for optimal proximal ESG sealing. The reinforcement of
the dilated aorta has been losing popularity because of the
poor results associated with sporadic cases of aortic wall
atrophy; however, in our technique described above, we
reinforce, without diminishing the diameter of the vessel,
a non-dilated aorta to prevent further dilatation. Thus far,
we have not experienced any aortic wall atrophy or rupture
in our follow-up (31.4  26.9 months), but caution is
advised in extrapolating the interpretation of these short-
and midterm results to predict long-term complications.
The reinforcement usually covers the resected origins of
the epi-aortic vessels, avoiding the little ‘cul de sac’; these
advantages allow a better conformation of the ESG
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instead of carotidecarotid or carotideLSA bypass, includes
the proximal complete disjunction of the supra-aortic
vessels from the aortic arch. This avoids the possibility of
a type 2 endoleak and prevents the possibility of cerebral
embolisation during ESG navigation through the aortic arch
and deployment. Demers et al.11 and Piffaretti et al.6
report that ESG landing in the proximity of the LSA or the
non-transposition of the LSA were independent risk factors
for endoleak because of a suboptimal landing zone, and
advocate choosing a rectilinear portion of the aorta for
effective and persistent sealing of the ESG. For these
reasons, we prefer to perform a complete debranching and
reinforcement of the aorta, instead of carotidecarotid or
carotideLSA bypass to treat Ishimaru zone 2 pathology.
Although it is generally accepted that a landing zone of
1.5 cm is adequate, not all operators agree.12e14 We
believe that a longer linear landing zone of more than 2 cm
must be achieved for optimal results. Despite the avoid-
ance of cardiopulmonary bypass and hypothermic circula-
tory arrest, debranching surgery is still highly invasive
requiring a median sternotomy. However, the incidence of
adverse neurologic events is low (ranging from 0% to 3%)9,12
and we report no ischaemic cerebral events or paraplegia/
paraparesis. We believe in preoperative evaluation of the
cerebral circulation and revascularise the LSA in all cases.
Buth et al.15 assessed the significance of clinical factors
that potentially influenced the occurrence of neurologic
sequelae during endovascular repair of the thoracic aorta:
perioperative paraplegia or paraparesis was significantly
associated with blockage of the LSA without revascularisa-
tion. In our series, only in the very first case was the LSA not
revascularised. We usually start the debranching with LSA
revascularisation to assure blood flow to the ipsilateral
vertebral artery during left carotid debranching. LSA
debranching is also crucial for avoiding paraplegia/para-
paresis, particularly in patients with previous repaired
abdominal aortic aneurysm; preservation of major collat-
erals of the vertebral artery that contribute to spinal blood
flow protects against spinal cord ischaemia when multiple
intercostal vessels are covered during thoracic endovas-
cular repair. Even though one patient died in the interval
period, while awaiting the endovascular step, we believe
that staging the procedures is beneficial for the patient. As
also reported by Huges et al.,9 the advantages of meta-
chronous procedures have demonstrated lower incidence of
spinal cord ischaemia compared with a single-stage
approach. During or immediately after a full debranching,
the ability to maintain supranormal mean arterial pressures
to augment spinal cord perfusion may be limited by
bleeding and the use of CSF drainage may be contra-
indicated owing to concerns over coagulopathy and central
nervous system complications.
This study is limited by a small number of patients that
affect the power of the study, and the few observation
endpoints limited the statistical analysis. Furthermore, it is
a single-centre experience with a retrospective analysis
although data were prospectively collected and the rela-
tively short follow-up does not allow to make definite
inference regarding the durability of this approach.
In summary, hybrid treatment for aortic arch disease
with debranching of the supra-aortic vessel followed by ESGappears safe and effective; the early results are promising
and, if confirmed, this technique will not only be suitable
for high-risk patients but it would also represent an alter-
native to conventional surgical therapy. The reinforcement
of the aorta associated with a complete debranching
ensures a long and safe landing zone for the ESG, reducing
the risk of endoleak. However, a longer follow-up is
mandatory to verify the promising early results. The
systematic revascularisation of the debranched LSA and
a two-staged approach provide better haemodynamic
stability to maintain perfusion of the central nervous
system.
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